195 related articles for article (PubMed ID: 14981238)
21. The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment.
Bawa-Khalfe T; Altememi GF; Mandyam CD; Schwarz LA; Eikenburg DC; Standifer KM
BMC Pharmacol; 2007 Dec; 7():16. PubMed ID: 18096057
[TBL] [Abstract][Full Text] [Related]
22. 3-Dimensional structures of G protein-coupled receptors and binding sites of agonists and antagonists.
Goddard WA; Abrol R
J Nutr; 2007 Jun; 137(6 Suppl 1):1528S-1538S; discussion 1548S. PubMed ID: 17513420
[TBL] [Abstract][Full Text] [Related]
23. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography.
Wacker D; Fenalti G; Brown MA; Katritch V; Abagyan R; Cherezov V; Stevens RC
J Am Chem Soc; 2010 Aug; 132(33):11443-5. PubMed ID: 20669948
[TBL] [Abstract][Full Text] [Related]
24. Ligand-binding affinity of alternative conformers of human β
Dilcan G; Doruker P; Akten ED
Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
[TBL] [Abstract][Full Text] [Related]
25. An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.
Chandramoorthi GD; Piramanayagam S; Marimuthu P
J Mol Model; 2008 Sep; 14(9):849-56. PubMed ID: 18512086
[TBL] [Abstract][Full Text] [Related]
26. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
Bhattacharya S; Hall SE; Li H; Vaidehi N
Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472
[TBL] [Abstract][Full Text] [Related]
27. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
Gether U; Lin S; Kobilka BK
J Biol Chem; 1995 Nov; 270(47):28268-75. PubMed ID: 7499324
[TBL] [Abstract][Full Text] [Related]
28. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
29. The importance of valine 114 in ligand binding in beta(2)-adrenergic receptor.
Arakawa M; Yanamala N; Upadhyaya J; Halayko A; Klein-Seetharaman J; Chelikani P
Protein Sci; 2010 Jan; 19(1):85-93. PubMed ID: 19916165
[TBL] [Abstract][Full Text] [Related]
30. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
Peng JY; Vaidehi N; Hall SE; Goddard WA
ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
[TBL] [Abstract][Full Text] [Related]
31. Insights into signaling from the beta2-adrenergic receptor structure.
Audet M; Bouvier M
Nat Chem Biol; 2008 Jul; 4(7):397-403. PubMed ID: 18560432
[TBL] [Abstract][Full Text] [Related]
32. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.
Parmee ER; Brockunier LL; He J; Singh SB; Candelore MR; Cascieri MA; Deng L; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE
Bioorg Med Chem Lett; 2000 Oct; 10(20):2283-6. PubMed ID: 11055339
[TBL] [Abstract][Full Text] [Related]
33. Identification of binding sites of bopindolol and its two metabolites with beta1-adrenoceptors by molecular modeling: comparison with beta2 adrenoceptors.
Hattori K; Ishiguro M; Ohnuki T; Nakamura T; Muramatsu I; Nagatomo T
Pharmacology; 1999 Apr; 58(4):183-9. PubMed ID: 10077737
[TBL] [Abstract][Full Text] [Related]
34. [β-arrestin2 recruitment by β-adrenergic receptor agonists and antagonists].
Wang YR; Cheng DQ; Ma L; Liu X
Sheng Li Xue Bao; 2022 Dec; 74(6):993-1004. PubMed ID: 36594387
[TBL] [Abstract][Full Text] [Related]
35. Examination of ligand-induced conformational changes in the beta2 adrenergic receptor.
Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P
Life Sci; 1998; 62(17-18):1509-12. PubMed ID: 9585127
[TBL] [Abstract][Full Text] [Related]
36. Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor.
Swaminath G; Lee TW; Kobilka B
J Biol Chem; 2003 Jan; 278(1):352-6. PubMed ID: 12409304
[TBL] [Abstract][Full Text] [Related]
37. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
[TBL] [Abstract][Full Text] [Related]
38. The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human
Lim VJY; Proudman RGW; Monteleone S; Kolb P; Baker JG
Mol Pharmacol; 2023 Feb; 103(2):89-99. PubMed ID: 36351797
[TBL] [Abstract][Full Text] [Related]
39. Characterization of porcine beta1- and beta2-adrenergic receptors in heart, skeletal muscle, and adipose tissue, and the identification of an atypical beta-adrenergic binding site.
Sillence MN; Hooper J; Zhou GH; Liu Q; Munn KJ
J Anim Sci; 2005 Oct; 83(10):2339-48. PubMed ID: 16160045
[TBL] [Abstract][Full Text] [Related]
40. Potent and selective human beta(3)-adrenergic receptor antagonists.
Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]